NaviFUS
Manufacturing · Taiwan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
no 246 Sec. 3 Chengde Rd. 12f, Taipei Ci...Website
www.navifus.comRevenue
<$5 MillionIndustry
About NaviFUS
NaviFUS Org Chart
Is NaviFUS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at NaviFUS
Earning: See what the market has to say on NaviFUS recently announced quarterly report
Check if NaviFUS has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once NaviFUS has new funding data
Click to see if NaviFUS had a recent Job posting/layoffs
Check out if NaviFUS is spiking on competitors!
Product Launch: Get notified when NaviFUS launches new products
Website visits: Recent activity has been detected on your website
NaviFUS, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at NaviFUS
Find 3 more new buyers
Company Profile Activity
Activity Insights
NaviFUS is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NaviFUS is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NaviFUS.
NaviFUS Tech Stack
A closer look at the technologies used by NaviFUS
Most Recent Scoops
NaviFUS News & Media
NaviFUS Corp. Leverages Taiwan's Advanced Chip Technology to Lead Non-Invasive Precision Medicine for Brain Disorders
TAIPEI, Feb. 19, 2025 /PRNewswire/ -- NaviFUS Corp. is dedicated to advancing non-invasive treatments for complex brain disorders, a challenging area in medical innovation. By using ultrasound technology for both diagnosis and therapy, NaviFUS exceeds the signal processing capabilities of...NaviFUS begins FUS combined with radiotherapy clinical trial for the treatment of terminal primary brain tumors
TAIPEI, Aug. 3, 2021 /PRNewswire/ -- NaviFUS' focused ultrasound (FUS) therapy system (NaviFUS®) was recently approved for use in a new clinical trial by the Taiwan Food and Drug Administration (TFDA). It will be initiated shortly at Linkou Chang Gung Memorial Hospital. The trial will...NaviFUS highlights clinical trial data and device capabilities at virtual International Focused Ultrasound Symposium
TAIPEI, Nov. 24, 2020 /PRNewswire/ -- The 7th International Focused Ultrasound Symposium organized by the U.S. Focused Ultrasound Foundation took place from 11/9 to 11/13 in virtual format this year due to the COVID-19 epidemic. During the 5-day conference, participants presented and...NaviFUS Launches Neuronavigation-guided Clinical Trial to Open the Blood-Brain-Barrier for Combination FUS-Bevacizumab Therapy in rGBM Patients
TAIPEI, Sept. 11, 2020 /PRNewswire/ -- Genovate Biotech (TPEX:4130) subsidiary and Taiwan-based focused ultrasound (FUS) manufacturer NaviFUS Corporation is pleased to announce the start of its clinical trial (NCT04446416) for the combination of FUS plus bevacizumab therapy. Researchers...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NaviFUS
NaviFUS is a company focused on developing innovative, non-invasive technology for treating central nervous system (CNS) diseases. Their primary products include a neuronavigation-guided transcranial focused ultrasound system and a needle tracking system designed for precise surgical guidance. The company aims to improve the lives of patients suffe... Read More